Differentiating Anti-NMDA receptor encephalitis from other diseases

Jump to navigation Jump to search

Anti-NMDA receptor encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anti-NMDA receptor encephalitis from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating Anti-NMDA receptor encephalitis from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating Anti-NMDA receptor encephalitis from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating Anti-NMDA receptor encephalitis from other diseases

CDC on Differentiating Anti-NMDA receptor encephalitis from other diseases

Differentiating Anti-NMDA receptor encephalitis from other diseases in the news

Blogs on Differentiating Anti-NMDA receptor encephalitis from other diseases

Directions to Hospitals Treating Anti-NMDA receptor encephalitis

Risk calculators and risk factors for Differentiating Anti-NMDA receptor encephalitis from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;AE Dheeraj Makkar, M.D.[2]

Overview

Differentiating Anti-NMDA Receptor Encephalitis from other Diseases

Antigen NMDA receptor NR1 Lgil CASPR2 AMPA receptor GABA B receptor Glycine receptor MgluR5


Age(median)/gender female : male 0·6–85 (21) 4:1 30–80 (60) 1:2 46–77 (60) 1:4 38–87 (60) 9:1 24–75 (62) 1:1 5–69 (43) 6:5 46, 15 1:1
Clinical syndrome 1.Prodromal Syndrome

2. Psychiatric Syndrome, seizures, amnesia 3.Movement disorders catatonia, autonomic instability,

Limbic encephalitis, tonic or facio-brachial dystonic seizures,

myoclonus


row 2, cell 3

References

Template:WH Template:WS